0 XP   0   0   0

Terns Pharmaceuticals Inc
Buy or Sell?

I guess you are interested in Terns Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Terns Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Terns Pharmaceuticals Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Terns Pharmaceuticals Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Terns Pharmaceuticals Inc. The closing price on 2022-09-23 was $5.16 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of Terns Pharmaceuticals Inc
Terns Pharmaceuticals Inc Daily Candlestick Chart

1.1. Profitability of Terns Pharmaceuticals Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Terns Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-147,937,856.2%+147,937,856.2%
TTM-147,937,856.2%YOY-7,456,944.4%-140,480,911.8%
TTM-147,937,856.2%5Y-56,507,200.2%-91,430,656.0%
5Y-56,507,200.2%10Y-56,507,200.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM-147,937,856.2%-275.9%-147,937,580.3%
YOY-7,456,944.4%-335.9%-7,456,608.5%
5Y-56,507,200.2%-469.8%-56,506,730.4%
10Y-56,507,200.2%-549.9%-56,506,650.3%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Terns Pharmaceuticals Inc:

  • The MRQ is -9.6%. Very bad. -2
  • The TTM is -8.4%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-8.4%-1.3%
TTM-8.4%YOY-22.2%+13.8%
TTM-8.4%5Y-21.9%+13.6%
5Y-21.9%10Y-21.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-9.8%+0.2%
TTM-8.4%-8.8%+0.4%
YOY-22.2%-9.2%-13.0%
5Y-21.9%-11.6%-10.3%
10Y-21.9%-12.7%-9.2%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Terns Pharmaceuticals Inc:

  • The MRQ is -10.2%. Very bad. -2
  • The TTM is -8.8%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-10.2%TTM-8.8%-1.4%
TTM-8.8%YOY-6.9%-1.9%
TTM-8.8%5Y-67.2%+58.4%
5Y-67.2%10Y-67.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.2%-11.9%+1.7%
TTM-8.8%-11.2%+2.4%
YOY-6.9%-10.6%+3.7%
5Y-67.2%-13.7%-53.5%
10Y-67.2%-14.5%-52.7%

1.2. Operating Efficiency of Terns Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Terns Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-148,350,345.3%+148,350,345.3%
TTM-148,350,345.3%YOY-7,512,500.0%-140,837,845.3%
TTM-148,350,345.3%5Y-56,677,398.3%-91,672,947.0%
5Y-56,677,398.3%10Y-56,677,398.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM-148,350,345.3%-269.6%-148,350,075.7%
YOY-7,512,500.0%-306.8%-7,512,193.2%
5Y-56,677,398.3%-461.8%-56,676,936.5%
10Y-56,677,398.3%-546.8%-56,676,851.5%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Terns Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1,483,503.720-1,483,503.720
TTM1,483,503.720YOY75,125.000+1,408,378.720
TTM1,483,503.7205Y566,774.080+916,729.640
5Y566,774.08010Y566,774.0800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM1,483,503.7203.662+1,483,500.058
YOY75,125.0003.692+75,121.308
5Y566,774.0805.743+566,768.337
10Y566,774.0806.919+566,767.161

1.3. Liquidity of Terns Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Terns Pharmaceuticals Inc:

  • The MRQ is 23.594. Very Good. +2
  • The TTM is 24.752. Very Good. +2
Trends
Current periodCompared to+/- 
MRQ23.594TTM24.752-1.158
TTM24.752YOY15.073+9.678
TTM24.7525Y14.890+9.862
5Y14.89010Y14.8900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.5945.318+18.276
TTM24.7526.219+18.533
YOY15.0736.366+8.707
5Y14.8906.760+8.130
10Y14.8906.520+8.370
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Terns Pharmaceuticals Inc:

  • The MRQ is 43.483. Very good. +2
  • The TTM is 42.285. Very good. +2
Trends
Current periodCompared to+/- 
MRQ43.483TTM42.285+1.198
TTM42.285YOY23.188+19.097
TTM42.2855Y23.943+18.342
5Y23.94310Y23.9430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ43.4834.107+39.376
TTM42.2854.994+37.291
YOY23.1885.257+17.931
5Y23.9435.338+18.605
10Y23.9435.050+18.893

1.4. Solvency of Terns Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Terns Pharmaceuticals Inc:

  • The MRQ is 0.053. Very good. +2
  • The TTM is 0.048. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.053TTM0.048+0.005
TTM0.048YOY0.691-0.643
TTM0.0485Y0.494-0.445
5Y0.49410Y0.4940.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0530.269-0.216
TTM0.0480.267-0.219
YOY0.6910.296+0.395
5Y0.4940.362+0.132
10Y0.4940.398+0.096
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Terns Pharmaceuticals Inc:

  • The MRQ is 0.056. Very good. +2
  • The TTM is 0.051. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.056TTM0.051+0.005
TTM0.051YOY0.108-0.057
TTM0.0515Y1.334-1.284
5Y1.33410Y1.3340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0560.305-0.249
TTM0.0510.303-0.252
YOY0.1080.309-0.201
5Y1.3340.382+0.952
10Y1.3340.436+0.898

2. Market Valuation of Terns Pharmaceuticals Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Terns Pharmaceuticals Inc:

  • The EOD is -2.422. Company is losing money. -2
  • The MRQ is -1.164. Company is losing money. -2
  • The TTM is -2.924. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-2.422MRQ-1.164-1.258
MRQ-1.164TTM-2.924+1.760
TTM-2.924YOY-6.900+3.976
TTM-2.9245Y-3.572+0.648
5Y-3.57210Y-3.5720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.422-2.088-0.334
MRQ-1.164-2.275+1.111
TTM-2.924-3.796+0.872
YOY-6.900-4.994-1.906
5Y-3.572-3.642+0.070
10Y-3.572-3.303-0.269
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of Terns Pharmaceuticals Inc:

  • The MRQ is -0.017. Very Bad. -2
  • The TTM is -0.047. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.017TTM-0.047+0.030
TTM-0.0475Y-0.0470.000
5Y-0.04710Y-0.0470.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0170.005-0.022
TTM-0.0470.020-0.067
5Y-0.0470.021-0.068
10Y-0.0470.017-0.064

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Terns Pharmaceuticals Inc:

  • The EOD is 0.952. Very good. +2
  • The MRQ is 0.457. Very good. +2
  • The TTM is 0.900. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.952MRQ0.457+0.494
MRQ0.457TTM0.900-0.442
TTM0.900YOY0.863+0.036
TTM0.9005Y0.641+0.259
5Y0.64110Y0.6410.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9521.808-0.856
MRQ0.4571.944-1.487
TTM0.9002.750-1.850
YOY0.8633.492-2.629
5Y0.6412.731-2.090
10Y0.6412.401-1.760

2.4. Latest News of Terns Pharmaceuticals Inc

Does Terns Pharmaceuticals Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Terns Pharmaceuticals Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-21
11:33
Zacks.com featured highlights include Terns Pharmaceuticals, Napco Security Technologies and AVEORead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Terns Pharmaceuticals Inc.

3.1. Institutions holding Terns Pharmaceuticals Inc

Institutions are holding 71.573% of the shares of Terns Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31Orbimed Advisors, LLC14.94730.1826379120400
2022-06-30Vivo Capital, LLC10.5470.6661267513300
2022-03-31Deerfield Management Co9.24920.1558234595900
2022-03-31FMR Inc9.15260.00062321458-479527-17.1199
2022-03-31Suvretta Capital Management, LLC4.88410.1124123880000
2022-06-30Antara Capital LP3.44820.0923874600-200234-18.6293
2022-03-31Vanguard Group Inc1.70720433019-125308-22.4435
2022-06-30Samsara BioCapital, LLC1.13970.191128906800
2022-03-31State Street Corporation0.6436016323712180.7518
2022-03-31Point72 Asset Management, L.P.0.48330.00151225731225730
2022-03-31Northern Trust Corp0.41330.0001104822-7214-6.439
2022-03-31Millennium Management LLC0.3490.0001885103522966.1193
2022-03-31CAAS CAPITAL MANAGEMENT LP0.33850.01058585100
2022-06-30Geode Capital Management, LLC0.3127079324-99987-55.7618
2022-03-31Renaissance Technologies Corp0.26730.000267800678000
2022-06-30Ergoteles LLC0.25020.004763454634540
2022-03-31Bridgeway Capital Management, LLC0.24720.003662700-32800-34.3455
2022-06-30Marquette Asset Management Inc.0.22820.0415787636074165.4619
2022-03-31Bank of New York Mellon Corp0.150103805923596.6078
2022-03-31Driehaus Capital Management LLC0.13840.001335100351000
Total 58.89711.463914938547  

3.2. Funds holding Terns Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Vanguard Total Stock Mkt Idx Inv0.9727024670400
2022-07-31Vanguard Extended Market Index Investor0.40980.000310393100
2022-07-29iShares Biotechnology ETF0.40470.0027102639-158-0.1537
2022-06-30Fidelity® Select Biotechnology0.39820.005210100900
2022-05-31Fidelity® Small Cap Index0.37930.00099620500
2022-06-30Bridgeway Ultra-Small Company Market0.16560.05484200000
2022-06-30Fidelity® Extended Market Index0.16370.00044152300
2022-03-31Fidelity NorthStar Sr F0.14820.00343760000
2022-07-29iShares Micro-Cap ETF0.12280.0073114300
2022-06-30Bailard Small Cal Value0.080.056920300203000
2022-06-30Bailard Micrcap Value0.080.191720300203000
2022-03-31iShares Russell 2000 Small-Cap Idx Instl0.07760.00141969000
2022-06-30Fidelity® NASDAQ Composite Index®0.05820.00041475600
2022-07-31Vanguard Balanced Index Inv0.05450.00011381300
2022-03-31Fidelity US Growth Opp Investment Trst O0.04380.01151110000
2022-07-29iShares Nasdaq US Biotech ETF USD Acc0.04210.00521067700
2022-06-30Fidelity® Total Market Index0.039701006700
2022-03-31Fidelity US Growth Opp Class A0.0370.01159391-56-0.5928
2022-06-30Fidelity® Series Total Market Index0.02890733000
2022-06-30NT Ext Equity Mkt Idx Fd - NL0.02740.0004696100
Total 3.73420.3538947139  

3.3. Insider Transactions

Insiders are holding 4.419% of the shares of Terns Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-16Hongbo LuBUY15000002.422981592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592
2022-08-15Vivo Opportunity, LlcBUY12182.991481592

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Terns Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--5.4236.124-11%5.796-6%4.383+24%4.383+24%
Current Ratio--23.59424.752-5%15.073+57%14.890+58%14.890+58%
Debt To Asset Ratio--0.0530.048+10%0.691-92%0.494-89%0.494-89%
Debt To Equity Ratio--0.0560.051+10%0.108-48%1.334-96%1.334-96%
Eps---0.550-0.533-3%-0.314-43%-0.416-24%-0.416-24%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----1479378.5620%-74569.4440%-565072.0020%-565072.0020%
Operating Margin----1483503.4530%-75125.0000%-566773.9830%-566773.9830%
Operating Ratio---1483503.720-100%75125.000-100%566774.080-100%566774.080-100%
Pb Ratio0.952+52%0.4570.900-49%0.863-47%0.641-29%0.641-29%
Pe Ratio-2.422-108%-1.164-2.924+151%-6.900+493%-3.572+207%-3.572+207%
Peg Ratio---0.017-0.047+179%---0.047+179%-0.047+179%
Price Per Share5.160+52%2.4805.735-57%8.565-71%5.200-52%5.200-52%
Quick Ratio--43.48342.285+3%23.188+88%23.943+82%23.943+82%
Return On Assets---0.096-0.084-13%-0.222+131%-0.219+128%-0.219+128%
Return On Equity---0.102-0.088-13%-0.069-32%-0.672+562%-0.672+562%
 EOD+1 -2MRQTTM+4 -9YOY+8 -45Y+10 -310Y+10 -3

4.2. Fundamental Score

Let's check the fundamental score of Terns Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.422
Price to Book Ratio (EOD)Between0-10.952
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than143.483
Current Ratio (MRQ)Greater than123.594
Debt To Asset Ratio (MRQ)Less than10.053
Debt to Equity Ratio (MRQ)Less than10.056
Return On Equity (MRQ)Greater than0.15-0.102
Return on Assets (MRQ)Greater than0.05-0.096
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Terns Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.162
Ma 20Greater thanMa 505.007
Ma 50Greater thanMa 1003.750
Ma 100Greater thanMa 2002.853
OpenGreater thanClose4.870
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets144,860
Total Liabilities7,644
Total Stockholder Equity137,216
 As reported
Total Liabilities 7,644
Total Stockholder Equity+ 137,216
Total Assets = 144,860

Assets

Total Assets144,860
Total Current Assets142,601
Long-term Assets142,601
Total Current Assets
Cash And Cash Equivalents 16,806
Short-term Investments 123,004
Other Current Assets 2,791
Total Current Assets  (as reported)142,601
Total Current Assets  (calculated)142,601
+/-0
Long-term Assets
Property Plant Equipment 2,195
Other Assets 64
Long-term Assets  (as reported)2,259
Long-term Assets  (calculated)2,259
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,044
Long-term Liabilities1,600
Total Stockholder Equity137,216
Total Current Liabilities
Short-term Debt 586
Accounts payable 973
Other Current Liabilities 4,485
Total Current Liabilities  (as reported)6,044
Total Current Liabilities  (calculated)6,044
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt851
Other Liabilities 749
Long-term Liabilities  (as reported)1,600
Long-term Liabilities  (calculated)1,600
+/-0
Total Stockholder Equity
Common Stock3
Retained Earnings -209,776
Accumulated Other Comprehensive Income -1,241
Capital Surplus 348,230
Total Stockholder Equity (as reported)137,216
Total Stockholder Equity (calculated)137,216
+/-0
Other
Capital Stock3
Cash and Short Term Investments 139,810
Common Stock Shares Outstanding 25,304
Common Stock Total Equity3
Liabilities and Stockholders Equity 144,860
Net Debt -15,369
Net Invested Capital 137,216
Net Tangible Assets 137,216
Net Working Capital 136,557
Short Long Term Debt Total 1,437



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
23,904
0
0
17,413
92,290
199,241
188,007
179,890
168,070
156,669
144,860
144,860156,669168,070179,890188,007199,24192,29017,4130023,904
   > Total Current Assets 
22,224
0
0
15,421
90,869
198,042
186,872
178,794
166,930
154,111
142,601
142,601154,111166,930178,794186,872198,04290,86915,4210022,224
       Cash And Cash Equivalents 
12,327
0
0
13,756
74,854
98,829
67,589
64,751
47,699
43,879
16,806
16,80643,87947,69964,75167,58998,82974,85413,7560012,327
       Short-term Investments 
7,323
0
0
0
0
96,752
117,495
112,445
118,283
107,389
123,004
123,004107,389118,283112,445117,49596,75200007,323
       Net Receivables 
0
0
0
0
12,718
12,718
0
0
0
0
0
0000012,71812,7180000
       Other Current Assets 
2,574
0
0
1,665
3,297
2,461
1,788
1,598
948
2,843
2,791
2,7912,8439481,5981,7882,4613,2971,665002,574
   > Long-term Assets 
1,680
0
0
1,992
1,421
1,199
1,135
1,096
1,140
2,558
2,259
2,2592,5581,1401,0961,1351,1991,4211,992001,680
       Property Plant Equipment 
961
0
0
1,234
1,175
1,025
959
927
1,046
2,486
2,195
2,1952,4861,0469279591,0251,1751,23400961
       Other Assets 
719
0
0
0
246
174
176
169
94
72
64
647294169176174246000719
> Total Liabilities 
19,697
0
0
42,261
23,698
9,239
6,675
7,734
7,767
7,953
7,644
7,6447,9537,7677,7346,6759,23923,69842,2610019,697
   > Total Current Liabilities 
4,950
0
0
28,023
22,821
8,377
5,818
6,893
6,820
6,165
6,044
6,0446,1656,8206,8935,8188,37722,82128,023004,950
       Short-term Debt 
0
0
0
19,337
12,880
12,880
0
0
0
584
586
58658400012,88012,88019,337000
       Short Long Term Debt 
0
0
0
19,337
12,880
0
0
0
0
0
0
00000012,88019,337000
       Accounts payable 
1,636
0
0
461
935
4,250
1,688
1,582
2,126
1,678
973
9731,6782,1261,5821,6884,250935461001,636
       Other Current Liabilities 
117
0
0
8,225
8,170
3,291
3,294
4,475
4,694
3,903
4,485
4,4853,9034,6944,4753,2943,2918,1708,22500117
   > Long-term Liabilities 
14,747
0
0
14,238
877
862
857
841
947
1,788
1,600
1,6001,78894784185786287714,2380014,747
       Other Liabilities 
630
0
0
0
877
862
857
841
947
788
749
749788947841857862877000630
       Deferred Long Term Liability 
0
0
0
0
0
208
193
176
0
0
0
00017619320800000
> Total Stockholder Equity
4,207
0
0
-24,848
68,592
190,002
181,332
172,156
160,303
148,716
137,216
137,216148,716160,303172,156181,332190,00268,592-24,848004,207
   Common Stock
0
0
0
0
0
3
3
3
3
3
3
33333300000
   Retained Earnings Total Equity-209,77600-167,825-155,990-145,25200000
   Accumulated Other Comprehensive Income 
-106
0
0
90
-124
-232
-174
-167
-338
-896
-1,241
-1,241-896-338-167-174-232-1249000-106
   Capital Surplus 
0
0
0
0
0
335,483
337,493
340,145
0
0
348,230
348,23000340,145337,493335,48300000
   Treasury Stock00000000000
   Other Stockholders Equity 
-106
0
0
0
-124
335,483
337,493
340,145
342,711
345,455
348,230
348,230345,455342,711340,145337,493335,483-124000-106



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue1,000
Cost of Revenue--
Gross Profit-1,000
 
Operating Income (+$)
Gross Profit-
Operating Expense-50,860
Operating Income-49,860-50,860
 
Operating Expense (+$)
Research Development31,311
Selling General Administrative19,549
Selling And Marketing Expenses-
Operating Expense50,86050,860
 
Net Interest Income (+$)
Interest Income170
Interest Expense--
Net Interest Income170170
 
Pretax Income (+$)
Operating Income-49,860
Net Interest Income170
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-49,650-50,070
EBIT - interestExpense = -49,650
-49,650
-50,158
Interest Expense-
Earnings Before Interest and Taxes (ebit)-49,650-49,650
Earnings Before Interest and Taxes (ebitda)-49,138
 
After tax Income (+$)
Income Before Tax-49,650
Tax Provision-508
Net Income From Continuing Ops-50,158-50,158
Net Income-50,158
Net Income Applicable To Common Shares-50,158
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses50,860
Total Other Income/Expenses Net210-170
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DAAPL.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DAAPL.CC.

DAAPL.CC Daily Candlestick Chart
UIP.CC
3 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of UIP.CC.

UIP.CC Daily Candlestick Chart
TRC.CC
3 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRC.CC.

TRC.CC Daily Candlestick Chart
TIX.CC
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIX.CC.

TIX.CC Daily Candlestick Chart
THC.CC
3 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TERC.CC
3 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
3 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
TBTC.CC
3 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TBTC.CC.

TBTC.CC Daily Candlestick Chart
SWACE.CC
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SWACE.CC.

SWACE.CC Daily Candlestick Chart
START.CC
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of START.CC.

START.CC Daily Candlestick Chart
SNC.CC
3 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SAVG.CC
3 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SAVG.CC.

SAVG.CC Daily Candlestick Chart
RPZX.CC
3 hours ago

I found you a Golden Cross on the daily chart of RPZX.CC.

RPZX.CC Daily Candlestick Chart
RIO.CC
3 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RIO.CC.

RIO.CC Daily Candlestick Chart
PYRK.CC
3 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRK.CC.

PYRK.CC Daily Candlestick Chart
PLAY.CC
3 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
pBTC35A.CC
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of pBTC35A.CC.

pBTC35A.CC Daily Candlestick Chart
PBTC.CC
3 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PBTC.CC.

PBTC.CC Daily Candlestick Chart
PASC.CC
3 hours ago

I found you a Golden Cross on the daily chart of PASC.CC.

PASC.CC Daily Candlestick Chart
OPCT.CC
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPCT.CC.

OPCT.CC Daily Candlestick Chart
NCDT.CC
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NCDT.CC.

NCDT.CC Daily Candlestick Chart
MSWAP.CC
3 hours ago

I found you a Death Cross on the daily chart of MSWAP.CC.

MSWAP.CC Daily Candlestick Chart
MERI.CC
3 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of MERI.CC.

MERI.CC Daily Candlestick Chart
MBC.CC
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MBC.CC.

MBC.CC Daily Candlestick Chart